Impact of a non ‐fluoridated microcrystalline hydroxyapatite dentifrice on enamel caries progression in highly caries‐susceptible orthodontic patients: A randomized, controlled 6‐month trial
ConclusionIn highly caries ‐active patients, the impact of the regular use of a microcrystalline HAP dentifrice on caries progression is not significantly different from the use of a 1400 ppm fluoride toothpaste (ClinicalTrials.gov: NCT02705456).
Source: Journal of Investigative and Clinical Dentistry - Category: Dentistry Authors: Ulrich Schlagenhauf,
Karl ‐Heinz Kunzelmann,
Christian Hannig,
Theodor W. May,
Helmut Hösl,
Mario Gratza,
Gabriele Viergutz,
Marco Nazet,
Sebastian Schamberger,
Peter Proff Tags: ORIGINAL ARTICLE Source Type: research